OptiBiotix Health

OPTIHealthcare
18.25GBX
0.00%
Market Cap
18.12M
Volume
90.86k
33% of avg
P/E Ratio
EPS (TTM)
Beta
1.74
Day Range
17.67p - 19.00p
52 Week Range
10.00p18.25p35.00p
18.25p

Upcoming Events

May 20, 2025
Launch of SlimBiome products with US partner
July 2025
Daily Nouri expected to reach annual 2025 forecast of 10 metric tonnes
High Impact Event
Q1 2026
Results Release (Q1 2026)
High Impact Event
OPTI
NEUTRAL

OptiBiotix Launches SlimBiome Products with US Partner

The life sciences company has launched its SlimBiome products with a NASDAQ-listed US partner, expanding its reach in the weight management market.

OPTI
GOOD

OptiBiotix secures first order from leading US weight management brand

The life sciences company has received its first order from a leading US weight management brand to incorporate its SlimBiome product into a range of flavored drinks.

OPTI
NEUTRAL

OptiBiotix Provides Commercial Update

The life sciences company reports progress on key strategic objectives, including increasing partners and sales in the USA and Asia, investing in e-commerce, and growing sales of branded and white label products.

OPTI
GOOD

OptiBiotix Launches New FeelFull Product in America

The life sciences company has launched a new weight management product in the US, partnering with a prominent brand to drive sales.

OPTI
GOOD

OptiBiotix Launches Products on Amazon India

Life sciences company launches weight management products on Amazon India, expanding reach in a key market.

OPTI
NEUTRAL

OptiBiotix Appoints New Finance Director to Drive Profitability

Biotechnology company appoints new Finance Director to improve financial management and drive profitability.

OPTI
NEUTRAL

OptiBiotix Health Plc Issues Options to CEO

The life sciences company has issued new options to its CEO, aligning his interests with long-term shareholder value.

OPTI
GOOD

OptiBiotix Launches SlimBiome-Containing Products in India with £1.5M+ Marketing Push

The life sciences company is launching its SlimBiome products in India through a partnership with a major local brand, backed by a £1.5M+ marketing push. This represents a significant growth opportunity for the business.

OPTI
BAD

OptiBiotix Seeks Removal of ProBiotix Directors Amid Governance Concerns

The life sciences company is embroiled in a corporate governance dispute, with a major shareholder seeking to remove the current directors amid concerns over transparency and performance.

OPTI
NEUTRAL

OptiBiotix Announces Directorate Change

Biotech company OptiBiotix announces changes to its leadership team, with the Finance Director stepping down and an experienced acting replacement being appointed.